Literature DB >> 18440142

Diffuse cortical atrophy in a marmoset model of multiple sclerosis.

Ian M Pomeroy1, Elaine K Jordan, Joseph A Frank, Paul M Matthews, Margaret M Esiri.   

Abstract

Marmoset experimental autoimmune encephalomyelitis (EAE) has previously been shown to replicate the essential features of both white matter and grey matter lesions of MS. This study set out to investigate whether cortical atrophy occurs in marmoset EAE and whether cortical thinning is related to the presence of focal, demyelinated cortical lesions. Seventeen leucocortical lesions and 13 subpial lesions were identified in 6 EAE cases. Cortical thickness surrounding these lesions was recorded and compared with matched cortical areas from five control animals. We found a diffuse 13-21% loss of cortical thickness in all areas of EAE cortex compared with control animals but there was no additional loss seen in demyelinated versus myelinated EAE cortex. These findings could not be accounted for by effects of age, sex and disease duration. We conclude that localised cortical demyelination is not responsible for the major part of the atrophy observed and that cortical thinning is largely due to more diffuse or more remote factors. Marmoset EAE is an invaluable tool which can be used to further investigate the cause and the substrate of cortical loss in demyelinating diseases.

Entities:  

Mesh:

Year:  2008        PMID: 18440142      PMCID: PMC2391306          DOI: 10.1016/j.neulet.2008.03.069

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.

Authors:  Arnaud Charil; Alain Dagher; Jason P Lerch; Alex P Zijdenbos; Keith J Worsley; Alan C Evans
Journal:  Neuroimage       Date:  2006-11-16       Impact factor: 6.556

2.  Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.

Authors:  Stephen W Scheff; Douglas A Price; Frederick A Schmitt; Elliott J Mufson
Journal:  Neurobiol Aging       Date:  2005-11-09       Impact factor: 4.673

3.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

Authors:  J W Peterson; L Bö; S Mörk; A Chang; B D Trapp
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

4.  Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey.

Authors:  Doron Merkler; Robert Böscke; Barthel Schmelting; Boldizsár Czéh; Eberhard Fuchs; Wolfgang Brück; Christine Stadelmann
Journal:  Brain Pathol       Date:  2006-04       Impact factor: 6.508

Review 5.  Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia.

Authors:  Paul M Thompson; Kiralee M Hayashi; Elizabeth R Sowell; Nitin Gogtay; Jay N Giedd; Judith L Rapoport; Greig I de Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; David M Doddrell; Yalin Wang; Theo G M van Erp; Tyrone D Cannon; Arthur W Toga
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

6.  Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.

Authors:  A Paolillo; C Pozzilli; C Gasperini; E Giugni; C Mainero; S Giuliani; V Tomassini; E Millefiorini; S Bastianello
Journal:  J Neurol Sci       Date:  2000-03-15       Impact factor: 3.181

7.  Grey matter pathology in multiple sclerosis.

Authors:  Marco Vercellino; Federica Plano; Barbara Votta; Roberto Mutani; Maria Teresa Giordana; Paola Cavalla
Journal:  J Neuropathol Exp Neurol       Date:  2005-12       Impact factor: 3.685

8.  Cortical demyelination and diffuse white matter injury in multiple sclerosis.

Authors:  Alexandra Kutzelnigg; Claudia F Lucchinetti; Christine Stadelmann; Wolfgang Brück; Helmut Rauschka; Markus Bergmann; Manfred Schmidbauer; Joseph E Parisi; Hans Lassmann
Journal:  Brain       Date:  2005-10-17       Impact factor: 13.501

9.  Focal thinning of the cerebral cortex in multiple sclerosis.

Authors:  Michael Sailer; Bruce Fischl; David Salat; Claus Tempelmann; Mircea Ariel Schönfeld; Evelina Busa; Nils Bodammer; Hans-Jochen Heinze; Anders Dale
Journal:  Brain       Date:  2003-06-04       Impact factor: 13.501

10.  Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

Authors:  N De Stefano; P M Matthews; M Filippi; F Agosta; M De Luca; M L Bartolozzi; L Guidi; A Ghezzi; E Montanari; A Cifelli; A Federico; S M Smith
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

View more
  17 in total

1.  Analysis of vascular homogeneity and anisotropy on high-resolution primate brain imaging.

Authors:  Pol Kennel; Caroline Fonta; Romain Guibert; Franck Plouraboué
Journal:  Hum Brain Mapp       Date:  2017-08-28       Impact factor: 5.038

2.  The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI.

Authors:  Constantina A Treaba; Elena Herranz; Valeria T Barletta; Ambica Mehndiratta; Russell Ouellette; Jacob A Sloane; Eric C Klawiter; Revere P Kinkel; Caterina Mainero
Journal:  J Neurol       Date:  2021-02-01       Impact factor: 4.849

3.  Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis.

Authors:  I Pirko; A J Johnson; Yi Chen; D M Lindquist; A K Lohrey; J Ying; R Scott Dunn
Journal:  Neuroimage       Date:  2010-09-15       Impact factor: 6.556

4.  Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging.

Authors:  Allan MacKenzie-Graham; Gilda A Rinek; Andrea Avedisian; Stefan M Gold; Andrew J Frew; Cynthia Aguilar; David R Lin; Elizabeth Umeda; Rhonda R Voskuhl; Jeffry R Alger
Journal:  Neuroimage       Date:  2011-12-13       Impact factor: 6.556

Review 5.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

Review 6.  Advanced MRI and staging of multiple sclerosis lesions.

Authors:  Martina Absinta; Pascal Sati; Daniel S Reich
Journal:  Nat Rev Neurol       Date:  2016-04-29       Impact factor: 42.937

Review 7.  Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy development.

Authors:  Yolanda S Kap; Jon D Laman; Bert A 't Hart
Journal:  J Neuroimmune Pharmacol       Date:  2009-10-14       Impact factor: 4.147

8.  An animal model of cortical and callosal pathology in multiple sclerosis.

Authors:  Mario Mangiardi; Daniel K Crawford; Xiaoyu Xia; Sienmi Du; Rebecca Simon-Freeman; Rhonda R Voskuhl; Seema K Tiwari-Woodruff
Journal:  Brain Pathol       Date:  2010-11-10       Impact factor: 6.508

9.  Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis.

Authors:  I M Pomeroy; E K Jordan; J A Frank; P M Matthews; M M Esiri
Journal:  Mult Scler       Date:  2010-03-01       Impact factor: 6.312

10.  Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.

Authors:  L K Fisniku; D R Altmann; M Cercignani; D J Tozer; D T Chard; J S Jackson; K A Miszkiel; K Schmierer; A J Thompson; D H Miller
Journal:  Mult Scler       Date:  2009-05-12       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.